- active not recruitingPHASE2, PHASE3
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
This study is testing a new medicine, linsitinib, for people with active, moderate to severe Thyroid Eye Disease (TED). Researchers want to see if it's safe and effective compared to a dummy pill over 24 weeks.
United States · Canada · Italy - active not recruiting
Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring
This study looks at how a small stick-on sensor can help new mums who had diabetes during pregnancy. It aims to find out if this sensor can predict their risk of developing diabetes again, more easily than current tests.
Canada - recruitingNA
Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM
This study looks at how a digital helper called covivio might ease the emotional stress linked to type 2 diabetes. 250 adults in Germany will take part to see if it helps improve their mood and health.
Germany - active not recruitingPHASE3
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
This study is looking at a new medicine called eneboparatide for people with long-term hypoparathyroidism. It aims to find out if the medicine is safe and effective in helping to manage the condition.
United States · Canada · Denmark - recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
The OSPREY Registry is looking at how a device called OncoSil™ works in people with locally advanced pancreatic cancer in normal hospital care. It watches how well the device performs and if there are any side effects when used with standard chemotherapy.
Spain · United Kingdom - recruitingNA
RT-CGM in Young Adults at Risk of DKA
This study looks at how a special device called real-time continuous glucose monitoring (RT-CGM) helps young adults, aged 18-25, manage their type 1 diabetes. We want to see if it improves blood sugar control and reduces hospital visits for high blood sugar.
United Kingdom